Literature DB >> 33212492

Preferentially Expressed Antigen in Melanoma (PRAME) Expression in Malignant, but Not Benign, Peripheral Nerve Sheath Tumors.

Cathryn R Cadwell1, Gul E Yuksek1, Angela C Hirbe2, Divya Srihari2, Phillip LeBoit3, Sonika Dahiya4, Melike Pekmezci1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33212492     DOI： 10.1093/jnen/nlaa125

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN： 0022-3069            Impact factor:   3.685


× No keyword cloud information.
  1 in total

1.  HMB45/PRAME, a Novel Double Staining for the Diagnosis of Melanocytic Neoplasms: Technical Aspects, Results, and Comparison With Other Commercially Available Staining (PRAME and Melan A/PRAME).

Authors:  Marco Grillini; Costantino Ricci; Vincenzo Pino; Silvia Pedrini; Michelangelo Fiorentino; Barbara Corti
Journal:  Appl Immunohistochem Mol Morphol       Date:  2022-01-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.